Nov 5, 2012 by Brenton Flynn1 Stock Racing After Walk Test DataWhy BioMarin shares are racing higher.
Oct 31, 2012 by Brenton FlynnToday's Health Care Pops and PlungesThese stocks were itching for the markets to open again.
Oct 31, 2012 by Brenton FlynnHansen Soars on Intuitive Surgical DealThese companies were itching for trading to open again.
Oct 29, 2012 by Brenton FlynnHurricane Sandy Hits Health Care EarningsPfizer, Vertex, and Acorda are the first to delay earnings announcements.
Oct 24, 2012 by Brenton Flynn and Max MacalusoXOMA Shares Up 150%, but in the Wrong Way XOMA shares fall hard on news of additional dilution.
Oct 24, 2012 by Brenton Flynn and Max Macaluso4 Stocks Looking to Dilute and ConquerCash can come at a steep price to investors.
Oct 23, 2012 by Brenton FlynnRegeneron Earnings: What You Have to WatchEylea sales are the number one priority.
Oct 23, 2012 by Brenton Flynn1 Company Diving off the Patent CliffFor Eli Lilly, it's all about the pipeline.
Oct 23, 2012 by Brenton FlynnThe Latest Non-Event for Obesity DrugsThe FDA cracks open the door to approval for Orexigen.
Oct 23, 2012 by Brenton FlynnAn Early Christmas for Flu Vaccine Companies?News to know as flu season kicks off.
Oct 22, 2012 by Brenton Flynn and Dave WilliamsonMore Good News for Pharma's Top StockNovo Nordisk receives more good news, this time from Europe.
Oct 22, 2012 by Brenton Flynn and Dave WilliamsonThings Don't Look Good for This DrugThis Cornerstone prospect should be crushed by the FDA.
Oct 22, 2012 by Brenton Flynn and Dave Williamson1 FDA Decision to Watch This WeekUnited Therapeutics awaits an FDA decision.
Oct 22, 2012 by Brenton Flynn and Dave WilliamsonWhy These Stocks Are Soaring HigherThese 3 stocks are putting the broader market to shame.
Oct 19, 2012 by Brenton Flynn1 Must Watch Trend in Medical DevicesEarnings call nuggets from across the medical devices industry.
Oct 19, 2012 by Brenton FlynnHealth Care Plunge: 4 Stocks Falling HardThese 4 health care stocks are falling hard on earnings and dilution.
Oct 18, 2012 by Brenton FlynnIs This the Most Dangerous Health Care Dividend?Huge risk and reward for those willing to buy shares of Questcor Pharmaceuticals.
Oct 18, 2012 by Brenton FlynnThe Dangers of Chasing Performance in BiotechIn this industry, do your homework before rushing in.
